About Precisis
Precisis is a company based in Heidelberg (Germany) founded in 2002. The company has 14 employees. Precisis operates in a competitive market with competitors including NeuroPace, Cadence Neuroscience, Engage Therapeutics, Cyberonics and CerboMed, among others.
- Headquarter Heidelberg, Germany
- Employees 14
- SectorsHealthcare
- Phone•••• ••••
- Website precisis.de
- Social LinkedIn
- Legal Name Precisis Aktiengesellschaft
- Latest Funding Round$2.83M (USD), Grant
Jun 2022
- Investors
- Employee Count14
Funding Insights of Precisis
- Total Rounds 1
- Last Round Grant — $2.83M
- First Round $2.83M
(Jun 2022)
- Investors Count 1
All 1 funding rounds of Precisis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $2.83M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Precisis
Precisis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium |
Investor details for Precisis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Precisis
10 people are tracked at Precisis (2 in leadership, 8 in team); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Joachim Schneider | Head of QM/RA | Leadership |
Michael Tittelbach | Managing Director And CTO | Leadership |
Aude Yulzari | Clinical Affairs Manager | Team |
Barbara S. | Sales Manager | Team |
Johannes Grosshauser | Senior Design Assurance Engineer | Team |
Alisa Öhrström | Produktmanager | Team |
Christian Wessinger | Senior Supply Chain Manager | Team |
Kevin S. Voss | Clinical Project Manager | Team |
Nina Moysich | Geschäftsführungs- Und Marketingassistenz | Team |
Shahrzad Zandi | Field Clinical Engineer – DACH Region And Portugal | Team |
Complete people profiles for Precisis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Precisis
2 dated milestones of Precisis across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Precisis is founded.
- Funding First funding round of $2.8M.
Competitors of Precisis
Precisis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroPace, Cadence Neuroscience, Engage Therapeutics, Cyberonics and CerboMed, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neuropace.com | 1997 | United States | $263.56M | 184 | Implantable neurostimulation systems for epilepsy treatment are developed. | |
| cadenceneuro.com | 2016 | Redmond, United States | $41.03M | – | Medical devices for treating neurological disorders like epilepsy are developed. | |
| engagetherapeutics.com | 2017 | Summit, United States | $30.6M | – | Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures | |
| cyberonics.com | 1987 | Houston, United States | – | 660 | Vagus nerve stimulation therapy is developed for epilepsy and depression. | |
| cerbomed.de | 2005 | Erlangen, Germany | $2.6M | – | Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders. | |
| nightwatchepilepsy.com | 2013 | Leiden, Netherlands | – | – | Wearable armbands for detecting epileptic seizures during sleep are offered. | |
| neurolinkmedical.com | 2007 | San Antonio, United States | $3.88M | – | Develops drug-device combinations for epilepsy treatment. | |
| squalusmed.com | 2019 | Caesarea, Israel | – | – | Image-guided laser platforms are developed for epilepsy treatment. |
Detailed competitors of Precisis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Precisis
The website of Precisis (precisis.de) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 19.7% vs previous month
Websites whose visitors overlap most with Precisis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rebmann-research.de | 100% | – | #6,717,502 | View details | |
| devicemed.de | 98% | 9.4K | #2,425,225 | View details | |
healthcare-digital.de | healthcare-digital.de | 98% | – | #3,105,485 | – |
monitor-versorgungsforschung.de | monitor-versorgungsforschung.de | 92% | – | #2,347,049 | – |
Latest news on Precisis
Complete news archive for Precisis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Precisis
10 companies that operate in the same segment as Precisis (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Precisis
Precisis was founded in 2002 and raised its 1st funding round 20 years after it was founded.
Precisis is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Precisis has 14 employees.
Precisis develops technologies and devices to treat various neurological conditions. The companys products include - Praezis Plus, a stereotactic 3D design software designed for the optimization of neurological surgical procedures; CobraLeaf MLC system that provides the ability to conform Cobalt-60 radiotherapy to the exact tumor shape without the cumbersome use of lead blocks. The company also provides EASEE, a minimally invasive brain stimulation system placed directly under the scalp for the treatment of epilepsy. In addition, the company offers surgical tools and radiation protection systems for neurosurgical brachytherapy, implantation hardware, and collimators. It provides solutions for precision interventions in neurosurgery, radiotherapy, and stereotaxy; and Parkinsons and tumors.
Precisis's top competitors include NeuroPace, Engage Therapeutics and Cyberonics.
Precisis has 1 investor. Key investors include EIC Fund.
Precisis operates through Precisis Aktiengesellschaft.